Detailed mechanisms by which pancreatic cancer affects the differentiation of myeloid cells remain controversial, but several markers of MDSCs [monocytic MDSC (CD11b+CD14+) or granulocytic MDSC (CD11b+CD15+)] have been reported (Goedegebuure et al., 2011). This evidence concerns the gene ITGAM and pancreatic neoplasm.